Stocks

In the preceding three months, 4 analysts have released ratings for Realty Income (NYSE:O), presenting a wide array of perspectives...

In the last three months, 5 analysts have published ratings on Calliditas Therapeutics (NASDAQ:CALT), offering a diverse range of perspectives...

Fusion Pharmaceuticals (NASDAQ:FUSN) said the Ontario Superior Court of Justice has approved its statutory plan of arrangement to be acquired...

Fate Therapeutics (NASDAQ:FATE) disclosed on Friday that chief financial officer Edward Dulac will resign from the company, effective June 14....

US indices rallied after a promising PCE report. The S&P 500 and Dow rallied, while the Nasdaq traded mostly flat....

The U.S. stock market ended a five-week positive streak as investors feared that slowing economic momentum could impact the earnings...

Update 6:20pm: Adds new United Therapeutics lawsuit against Liquidia. Liquidia (NASDAQ:LQDA) jumped 12% in after hours trading after a judge...

A recent company note from Piper Sandler & Co, by senior analysts Michael S. Lavery and Luke Maloney offers insights into...

OpenAI CEO Sam Altman has been hit with a bout of bad press in the past few weeks, which has...

Crude oil futures fell for the day and the week, ahead of this weekend's OPEC+ meeting where the group is...